TMCnet News
U.S. Patents Awarded to Inventors in Massachusetts (May 17)(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., May 17 -- The following federal patents were awarded to inventors in Massachusetts. *** Aphios Assigned Patent ALEXANDRIA, Va., May 17 -- Aphios, Woburn, Mass., has been assigned a patent (8,440,614) developed by Trevor P. Castor, Arlington, Mass., for "polymer microspheres/nanospheres and encapsulating therapeutic proteins therein." The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention is an improved process to formulate polymeric microspheres/nanospheres and encapsulate therapeutic proteins or other useful substances, and a polymer sphere apparatus. The invention is also methods of purifying protein-containing-polymeric-microspheres from unused polymer, and an apparatus therefore." The patent application was filed on Dec. 2, 2011 (13/310,169). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,440,614&OS=8,440,614&RS=8,440,614 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Analog Devices Assigned Patent ALEXANDRIA, Va., May 17 -- Analog Devices, Norwood, Mass., has been assigned a patent (8,441,492) developed by four co-inventors for "methods and apparatus for image processing at pixel rate." The co-inventors are Michael Meyer-Pundsack, Egenburg, Germany, Boris Lerner, Sharon, Mass., Gopal Gudhur Karanam, Bangalore, India, and Pradip Thaker, Gujarat, India. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments of the present invention provide for improved timing control in 2-D image processing to maintain a constant rate of memory fetches and pixel outputs even when the processing operations transition to a new line or frame of pixels. A one-to-one relationship between incoming pixel rate and outgoing pixel rate is maintained without additional clock cycles or memory bandwidth as an improved timing control according to the present invention takes advantage of idle memory bandwidth by pre-fetching a new column of pixel data in a first pixel block of a next line or frame while a new column of an edge pixel block on a current line is duplicated or zeroed out. As the edge pixel block(s) on the current line are processed, the data in the first pixel block of the next line or frame become ready for computation without extra clock cycles or extra memory bandwidth." The patent application was filed on Jan. 20, 2012 (13/354,819). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,492&OS=8,441,492&RS=8,441,492 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** E Ink Assigned Patent ALEXANDRIA, Va., May 17 -- E Ink, Cambridge, Mass., has been assigned a patent (8,441,714) developed by four co-inventors for multi-color electrophoretic displays. The co-inventors are Richard J. Paolini Jr., Framingham, Mass., George G. Harris, Woburn, Mass., Jonathan D. Albert, Philadelphia, and Barrett Comiskey, Shanghai, China. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A multi-color electrophoretic medium contains first, second and third species of particles, the particles having substantially non-overlapping electrophoretic mobilities and bring of three different colors. The particles are dispersed in a fluid having a fourth color. A method for driving such a display is also described." The patent application was filed on Oct. 3, 2011 (13/251,457). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,714&OS=8,441,714&RS=8,441,714 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Adobe Systems Assigned Patent ALEXANDRIA, Va., May 17 -- Adobe Systems, San Jose, Calif., has been assigned a patent (8,441,496) developed by Mark E. Maguire, Woburn, Mass., for a "method and system for modifying and rendering scenes via display lists." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Various embodiments of a method and system for modifying and rendering scenes via display lists are described. Various embodiments may include a graphical application for generating a display list including display list nodes each corresponding to a respective scene element. To generate a given display list node, the graphical application may determine a scene graph node of a scene graph, allocate a portion of memory dedicated to the display list node, and store in that portion of memory, at least one of the attributes of the respective scene element determined from the particular scene graph node. The graphical application may modify a particular display list node corresponding to the particular scene element by modifying a respective attribute stored in the portion of memory allocated to the particular display list node, and render an image of a scene that includes the particular scene element modified according to the notification." The patent application was filed on Sept. 30, 2008 (12/242,537). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,496&OS=8,441,496&RS=8,441,496 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Sperian Eye & Face Protection Assigned Patent ALEXANDRIA, Va., May 17 -- Sperian Eye & Face Protection, Smithfield, R.I., has been assigned a patent (8,441,724) developed by Xiaorong You, Shrewsbury, Mass., and Phil Johnson, Charlton, Mass., for a "IR filters with high VLT and neutral color." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An optical filter composite is provided having effective filtering of infrared emissions, such as solar or laser emissions, while providing very high visible light transmission, preserving the ability to differentiate and recognize colors and providing a pleasing overall color as compared to the prior art. The present invention provides for filters that are formed by lamination, infusion and/or coating processes using filtering assemblies having a neutral color with high visible light transmission while also producing high levels of filtration in the infrared and near infrared range to provide effective protection against harmful emissions in these ranges while also producing a filter that has a color that is more pleasing and desirable to the wearer." The patent application was filed on July 8, 2010 (12/832,284). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,724&OS=8,441,724&RS=8,441,724 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Nvidia Assigned Patent for Compression Tag State Interlock ALEXANDRIA, Va., May 17 -- Nvidia, Santa Clara, Calif., has been assigned a patent (8,441,495) developed by four co-inventors for a "compression tag state interlock." The co-inventors are James M. Van Dyke, Austin, Texas, John H. Edmondson, Arlington, Mass., Brian D. Hutsell, Fort Worth, Texas, and Michael F. Harris, Raleigh, N.C. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods for determining a compression tag state prior to memory client arbitration may reduce the latency for memory accesses. A compression tag is associated with each portion of a surface stored in memory and indicates whether or not the data stored in each portion is compressed or not. A client uses the compression tags to construct memory access requests and the size of each request is based on whether or not the portion of the surface to be accessed is compressed or not. When multiple clients access the same surface the compression tag reads are interlocked with the pending memory access requests to ensure that the compression tags provided to each client are accurate. This mechanism allows for memory bandwidth optimizations including reordering memory access requests for efficient access." The patent application was filed on Dec. 29, 2009 (12/649,196). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,495&OS=8,441,495&RS=8,441,495 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** E Ink Assigned Patent ALEXANDRIA, Va., May 17 -- E Ink, Cambridge, Mass., has been assigned a patent (8,441,716) developed by Richard J. Paolini Jr., Framingham, Mass., Steven Joseph Battista, Dorchester, Mass., and Jonathan D. Albert, Philadelphia, for "electro-optic displays, and color filters for use therein." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for producing a color electro-optic display uses an electro-optic sub-assembly comprising an electro-optic layer and a light-transmissive electrically-conductive layer. This sub-assembly is laminated to a backplane comprising a plurality of electrodes with the electro-optic layer disposed between the backplane and the electrically-conductive layer. A flowable material is placed over the sub-assembly and a color filter array is placed over the electrically-conductive layer and aligned with the electrodes of the backplane to form the color electro-optic display." The patent application was filed on Dec. 13, 2011 (13/324,536). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,716&OS=8,441,716&RS=8,441,716 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Cisco Technology Assigned Patent for a SG3-to-G3 Fax Spoof ALEXANDRIA, Va., May 17 -- Cisco Technology, San Jose, Calif., has been assigned a patent (8,441,669) developed by Hanh Huu Luong, Santa Barbara, Calif., and Brooks Stevens Read, Concord, Mass., for a SG3-to-G3 fax spoof. The abstract of the patent published by the U.S. Patent and Trademark Office states: "In one embodiment, an originating gateway receives a call menu (CM) signal from an originating fax machine. The CM signal may have been generated in response to an ANSam signal from a terminating fax machine. The originating gateway suppresses the CM signal after a preamble of the CM signal and generates a modified JM signal in response to receiving the CM signal. The modified JM signal indicates that V.34 half-duplex modulation is not an option. The originating gateway transmits the modified JM signal to the originating fax machine, which allows the transmission to continue across an unenhanced T.38 fax relay." The patent application was filed on March 2, 2010 (12/715,953). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,669&OS=8,441,669&RS=8,441,669 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Pixtronix Assigned Patent ALEXANDRIA, Va., May 17 -- Pixtronix, San Diego, has been assigned a patent (8,441,602) developed by Je Hong Kim, Lexington, Mass., and Jignesh Gandhi, Burlington, Mass., for "light guides and backlight systems incorporating prismatic structures and light redirectors." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Improved apparatus and method for collecting and directing light from a source via a light guide and modulated display assembly in an efficient manner through the design and use of prismatic optical structures, diffusers and/or light redirectors." The patent application was filed on July 6, 2012 (13/542,976). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,602&OS=8,441,602&RS=8,441,602 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Invention Science Fund I Assigned Patent ALEXANDRIA, Va., May 17 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,442,281) developed by eight co-inventors for an "artificially displaying information relative to a body." The co-inventors are Edward K.Y. Jung, Bellevue, Wash., Eric C. Leuthardt, St. Louis, Royce A. Levien, Lexington, Mass., Robert W. Lord, Seattle, Mark A. Malamud, Seattle, John D. Rinaldo Jr., Bellevue, Wash., Clarence T. Tegreene, Bellevue, Wash., and Lowell L. Wood Jr., Livermore, Calif. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system are described for generating a pattern indicating at least medical information related to an individual's body; and invoking circuitry for displaying at least the generated pattern on one or more surfaces on the individual's body." The patent application was filed on April 28, 2006 (11/414,149). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,281&OS=8,442,281&RS=8,442,281 Written by Arpi Sharma; edited by Anand Kumar. *** Google Assigned Patent for Determining Popularity Ratings Using Social and Interactive Applications for Mass Media ALEXANDRIA, Va., May 17 -- Google, Mountain View, Calif., has been assigned a patent (8,442,125) developed by Michele Covell, Palo Alto, Calif., Shumeet Baluja, Santa Clara, Calif., and Michael Fink, Brookline, Mass., for "determining popularity ratings using social and interactive applications for mass media." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems, methods, devices, and computer program products provide social and interactive applications for mass media based on real time ambient-audio and/or video identification. In some implementations, a method includes: receiving descriptors identifying ambient audio associated with a media broadcast; comparing the descriptors to one or more reference descriptors; and determining a rating for the media broadcast based at least in part on the results of the comparison." The patent application was filed on Nov. 27, 2006 (11/563,653). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,125&OS=8,442,125&RS=8,442,125 Written by Arpi Sharma; edited by Anand Kumar. *** American Science and Engineering Assigned Patent ALEXANDRIA, Va., May 17 -- American Science and Engineering, Billerica, Mass., has been assigned a patent (8,442,186) developed by Peter Rothschild, Newton, Mass., and Ming Zhang, Wayland, Mass., for a "backscatter energy analysis for classification of materials based on positional non-commutativity." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system and methods for characterizing regions within, or on, an inspected object, wherein a lower-Z scattering material and a higher-Z material may both lie along a common line of sight. The inspected object is scanned with penetrating radiation characterized by an energy distribution, and penetrating radiation scattered by the inspected object is detected in a manner that generates two detector signals that distinguish between materials of higher and lower effective atomic number under distinct sets of conditions with respect to the energy distribution of the penetrating radiation. An image is generated, based on a function of the two detector signals, as is a differential image, so as to allow distinction of higher-Z and lower-Z materials." The patent application was filed on Feb. 8, 2012 (13/368,610). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,186&OS=8,442,186&RS=8,442,186 Written by Arpi Sharma; edited by Anand Kumar. *** Paratek Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Paratek Pharmaceuticals, Boston, has been assigned a patent (8,440,646) developed by Michael N. Alekshun, Marlboro, N.J., and S. Ken Tanaka, Needham, Mass., for "substituted tetracycline compounds for treatment of Bacillus anthracis infections." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and compositions for the treatment of Bacillus anthracis infections are described." The patent application was filed on Oct. 10, 2007 (11/870,317). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,646.PN.&OS=PN/84,40,646&RS=PN/84,40,646 Written by Amal Ahmed; edited by Jaya Anand. *** Inotek Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Inotek Pharmaceuticals, Lexington, Mass., has been assigned a patent (8,440,639) developed by Norman N. Kim, Westford, Mass., William K. McVicar, Sudbury, Mass., and Thomas G. McCauley, Cambridge, Mass., for "combination compositions for reducing intraocular pressure." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided herein is a pharmaceutical composition or a kit comprising a combination of a carbonic anhydrase inhibitor analog and an adenosine A.sub.1 receptor agonist. Also provided herein is a method of reducing intraocular pressure (IOP) in a subject using such a combination or kit. In a particular embodiment, provided herein is a combination of dorzolamide marketed under the brand Trusopt.TM. and Compound A." The patent application was filed on March 18, 2011 (13/051,633). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,639.PN.&OS=PN/84,40,639&RS=PN/84,40,639 Written by Amal Ahmed; edited by Jaya Anand. *** Quercegen Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Quercegen Pharmaceuticals, Marlborough, Mass., has been assigned a patent (8,440,704) developed by Thomas Christian Lines, Wayland, Mass., for quercetin-containing compositions. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to a composition containing quercetin, vitamin B3, and vitamin C. Also disclosed is a method of using the composition for enhancing physical or mental performance or treating various diseases or disorders." The patent application was filed on Dec. 16, 2009 (12/639,212). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,704.PN.&OS=PN/84,40,704&RS=PN/84,40,704 Written by Amal Ahmed; edited by Jaya Anand. *** Whitehead Institute for Biomedical Research, FoldRx Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Whitehead Institute for Biomedical Research, Cambridge, Mass., and FoldRx Pharmaceuticals, Cambridge, Mass., have been assigned a patent (8,440,705) developed by Susan L. Lindquist, Chestnut Hill, Mass., Tiago Outeiro, Cambridge, Mass., and Richard Labaudiniere, Sherborn, Mass., for "compounds, compositions and methods of inhibiting alpha-synuclein toxicity." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds and compositions are provided for treatment or amelioration of one or more symptoms of .alpha.-synuclein toxicity, .alpha.-synuclein mediated diseases or diseases in which .alpha.-synuclein fibrils are a symptom or cause of the disease. In one embodiment, the compounds for use in the compositions and methods are heteroaryl acylguanidines, heteroarylhydrazones, dihydropyridones, heteroaryl and aryl styryl ketones, and heteroarylpyrazoles." The patent application was filed on Sept. 16, 2005 (11/575,481). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,705.PN.&OS=PN/84,40,705&RS=PN/84,40,705 Written by Amal Ahmed; edited by Jaya Anand. *** Genzyme Assigned Patent ALEXANDRIA, Va., May 17 -- Genzyme, Cambridge, Mass., has been assigned a patent (8,440,793) developed by six co-inventors for "peptide analogs of alpha-melanocyte stimulating hormone." The co-inventors are Michael A. Perricone, Sudbury, Mass., John Lyle Dzuris, Roslindale, Mass., Timothy E. Weeden, Sturbridge, Mass., James E. Stefano, Hopkinton, Mass., Clark Q. Pan, Sudbury, Mass., and Andrea E. Edling, Milford, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided herein are stable peptide analogs of the native alpha-melanocyte stimulating hormone (.alpha.-MSH) having selectivity for the melanocortin 1 receptor (MC1R). Also provided herein are pharmaceutical preparations of the .alpha.-MSH peptide analogs, as well as methods of using these analogs in the treatment of medical and veterinary conditions involving MC1R." The patent application was filed on March 20, 2009 (12/408,560). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,793.PN.&OS=PN/84,40,793&RS=PN/84,40,793 Written by Amal Ahmed; edited by Jaya Anand. *** Gefemer Research Acquisitions Assigned Patent ALEXANDRIA, Va., May 17 -- Gefemer Research Acquisitions, Wilmington, Del., has been assigned a patent (8,441,337) developed by Gene S. Fein, Lenox, Mass., and Edward Merritt, Lenox, Mass., for a "multicomputer data transferring and file accessing to authenticate online voting and registration in a secure database system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system is provided for file accessing and data transferring to secure online voting using a multilayered security system where all contents of the data may be delivered to users of varied electronic devices. The data transferring occur as an external communication between separate computers which themselves are distinguishable processing entities, such as a voter processing center, online voting station, registration station, and calling station. The system includes (i) requesting at least one voter and biometric information based on a security level; (ii) receiving the at least one voter and biometric information from the user; (iii) verifying the at least one voter and biometric information against the stored voter and biometric information; (iv) in response to acceptable verifications, sending a voting ballot; and (v) receiving and storing the voting ballot with a vote selection. The security level may depend on the type of ballot." The patent application was filed on July 8, 2010 (12/832,891). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,337.PN.&OS=PN/8,441,337&RS=PN/8,441,337 Written by Kusum Sangma; edited by Anand Kumar. *** Harvard College, Dana-Farber Cancer Institute Assigned Patent ALEXANDRIA, Va., May 17 -- Harvard College, Cambridge, Mass., and Dana-Farber Cancer Institute, Boston, have been assigned a patent (8,440,716) developed by Weiping Tang, Middleton, Wis., James Elliot Bradner, Cambridge, Mass., and Stuart L. Schreiber, Boston, for "deacetylase inhibitors and uses thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides novel compounds of formula (I) and pharmaceutical compositions thereof. The inventive compounds are useful as deacetylase inhibitors (e.g., histone deacetylase inhibitors) and may be useful in the treatment of proliferative diseases such as cancer. In particular, the inventive compounds are HDAC6 inhibitors. The invention also provide synthetic methods for preparing the inventive compounds." The patent application was filed on July 22, 2009 (13/055,241). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,716.PN.&OS=PN/84,40,716&RS=PN/84,40,716 Written by Amal Ahmed; edited by Jaya Anand. *** Vertex Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Vertex Pharmaceuticals, Cambridge, Mass., has been assigned a patent (8,440,706) developed by six co-inventors for "inhibitors of serine proteases." The co-inventors are Kevin M. Cottrell, Cambridge, Mass., John Maxwell, Hingham, Mass., Qing Tang, Acton, Mass., Anne-Laure Grillot, Somerville, Mass., Arnaud Le Tiran, Lexington, Mass., and Emanuele Perola, Brookline, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to compounds of formula I: ##STR00001## or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease." The patent application was filed on Feb. 28, 2011 (13/036,930). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,706.PN.&OS=PN/84,40,706&RS=PN/84,40,706 Written by Amal Ahmed; edited by Jaya Anand. *** Janssen Alzheimer Immunotherapy, Wyeth Assigned Patent ALEXANDRIA, Va., May 17 -- Janssen Alzheimer Immunotherapy, Dublin, Ireland, and Wyeth, Madison, N.J., have been assigned a patent (8,440,799) developed by Ranganathan Godavarti, Burlington, Mass., and Timothy Iskra, Derry, N.H., for "methods of purifying anti A .beta. antibodies." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present application provides methods of purifying A.beta. binding proteins having a Fc region, for example, anti-A.beta. antibodies or antibody fusions, by adsorbing the A.beta. binding protein to a Fc binding agent, such as, for example, Protein A or Protein G, followed by a wash with a divalent cation salt buffer to remove impurities and subsequent recovery of the adsorbed A.beta. binding protein. The present application also features methods of eluting the purified A.beta. binding protein as well as the incorporation of the methods within a purification train. Kits comprising components for carrying out the methods and instructions for use are also provided." The patent application was filed on Oct. 12, 2010 (12/903,053). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,799.PN.&OS=PN/84,40,799&RS=PN/84,40,799 Written by Amal Ahmed; edited by Jaya Anand. *** Saladax Biomedical Assigned Patent ALEXANDRIA, Va., May 17 -- Saladax Biomedical, Bethlehem, Pa., has been assigned a patent (8,440,796) developed by five co-inventors for "lenalidomide and thalidomide immunoassays." The co-inventors are Salvatore J. Salamone, Stockton, N.J., Jodi Blake Courtney, Doylestown, Pa., Alexander Volkov, Allentown, Pa., Howard Sard, Arlington, Mass., and Vishnumurthy Hegde, Chelmsford, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids." The patent application was filed on Nov. 23, 2011 (13/303,356). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,796.PN.&OS=PN/84,40,796&RS=PN/84,40,796 Written by Amal Ahmed; edited by Jaya Anand. *** Brigham and Women's Hospital Assigned Patent ALEXANDRIA, Va., May 17 -- Brigham and Women's Hospital, Boston, has been assigned a patent (8,440,718) developed by James L. Madara, Winchester, Mass., Charles N. Serhan, Needham, Mass., and Sean P. Colgan, Newton, Mass., for a "modulation of inflammation related to columnar epithelia." The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention provides pharmaceutical compositions containing lipoxin compounds and therapeutic uses for the compounds in treating or preventing a disease or condition associated with columnar epithelial inflammation. The invention also discloses methods for screening for compounds useful in preventing columnar epithelial inflammation." The patent application was filed on Jan. 22, 2004 (10/762,388). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,718.PN.&OS=PN/84,40,718&RS=PN/84,40,718 Written by Amal Ahmed; edited by Jaya Anand. *** Point Somee Limited Liability Assigned Patent ALEXANDRIA, Va., May 17 -- Point Somee Limited Liability, Dover, Del., has been assigned a patent (8,441,210) developed by four co-inventors for an "adaptive current regulation for solid state lighting." The co-inventors are Anatoly Shteynberg, San Jose, Calif., Harry Rodriguez, Gilroy, Calif., Bradley M. Lehman, Belmont, Mass., and Dongsheng Zhou, San Jose, Calif. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Exemplary embodiments provide an apparatus, system and method for power conversion to provide power to solid state lighting, and which may be coupled to a first switch, such as a dimmer switch. An exemplary system for power conversion comprises: a switching power supply comprising a second, power switch; solid state lighting coupled to the switching power supply; a voltage sensor; a current sensor; a memory; a first adaptive interface circuit to provide a resistive impedance to the first switch and conduct current from the first switch in a default mode; a second adaptive interface circuit to create a resonant process when the first switch turns on; and a controller to modulate the second adaptive interface circuit when the first switch turns on to provide a current path during the resonant process of the switching power supply." The patent application was filed on Dec. 16, 2009 (12/639,255). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,210.PN.&OS=PN/8,441,210&RS=PN/8,441,210 Written by Kusum Sangma; edited by Anand Kumar. *** Raytheon Assigned Patent ALEXANDRIA, Va., May 17 -- Raytheon, Waltham, Mass., has been assigned a patent (8,441,385) developed by Michael G. Adlerstein, Wellesley, Mass., for a "power digital to analog converter." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A digital to analog converter having a plurality of power dividers interconnected into a binary tree configuration, each one having an input and a pair of electrically isolated outputs for dividing power of an input signal at the input equally between the pair of outputs. A plurality of amplifiers is coupled between one of the pair of outputs of the one of the power dividers in one stage of the tree and the input of one of the power dividers in a succeeding stage of the tree. A power combiner is coupled between outputs of the amplifiers in a last one of the stages and an output of the analog to digital converter." The patent application was filed on May 19, 2011 (13/111,059). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,385.PN.&OS=PN/8,441,385&RS=PN/8,441,385 Written by Kusum Sangma; edited by Anand Kumar. *** Massachusetts Institute of Technology Assigned Patent ALEXANDRIA, Va., May 17 -- Massachusetts Institute of Technology, Cambridge, Mass., has been assigned a patent (8,440,835) developed by Barbara Imperiali, Cambridge, Mass., and Galen S. Loving, Somerville, Mass., for an environmentally sensitive fluorophores. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention generally relates to environment-sensitive fluorophores, including environment-sensitive fluorophores for reporting protein/protein and peptide/protein interactions. In one aspect, the present invention is directed to compounds and salts thereof, compositions and methods useful in determining biological interactions. In some cases, the compounds of the present invention are environment-sensitive fluorophores that have spectroscopic behavior that may depend on factors such as the physicochemical properties of the surrounding environment. The compounds of the present invention can be used, in certain embodiments, to monitor ions, small molecules, and biological processes such as protein folding, protein-protein interactions and phosphorylation events." The patent application was filed on Feb. 26, 2008 (12/449,785). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,440,835&OS=8,440,835&RS=8,440,835 Written by Arpi Sharma; edited by Anand Kumar. *** Amgen Assigned Patent ALEXANDRIA, Va., May 17 -- Amgen, Thousand Oaks, Calif., has been assigned a patent (8,440,674) developed by thirteen co-inventors for "substituted pyrimidine compounds as RAF inhibitors and methods of use." The co-inventors are Frenel F. De Morin, Thousand Oaks, Calif., Jian J. Chen, Camarillo, Calif., Elizabeth M. Doherty, Thousand Oaks, Calif., Stephen A. Hitchcock, Juniper, Fla., Qi Huang, Moorpark, Calif., Joseph L. Kim, Wayland, Mass., Gang Liu, Oak Park, Calif., Thomas Nixey, Newbury Park, Calif., Nick A. Paras, San Francisco, Jeffrey Petkus, Reseda, Calif., Daniel Martin Retz, Yorba Linda, Calif., Adrian Leonard Smith, Simi Valley, Calif., and Jiawang Zhu, Shanghai, China. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have a general Formula I ##STR00001## wherein R.sup.1 is ##STR00002## and A.sup.1, A.sup.2, A.sup.3, A.sup.4, X, Z, Z', R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention." The patent application was filed on June 17, 2011 (13/163,666). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,674.PN.&OS=PN/84,40,674&RS=PN/84,40,674 Written by Amal Ahmed; edited by Jaya Anand. *** WiTricity Assigned Patent ALEXANDRIA, Va., May 17 -- WiTricity, Watertown, Mass., has been assigned a patent (8,441,154) developed by 11 co-inventors for a "multi-resonator wireless energy transfer for exterior lighting." The co-inventors are Aristeidis Karalis, Boston, Andre B. Kurs, Chestnut Hill, Mass., Andrew J. Campanella, Somerville, Mass., David A. Schatz, Needham, Mass., Herbert Toby Lou, Carlisle, Mass., Morris P. Kesler, Bedford, Mass., Katherine L. Hall, Westford, Mass., Konrad Kulikowski, North Andover, Mass., Eric R. Giler, Boston, Ron Fiorello, Tewksbury, Mass., and Marin Soljacic, Belmont, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A mobile wireless receiver for use with a first electromagnetic resonator coupled to a power supply and a second electromagnetic resonator coupled to at least one of a power supply and the first electromagnetic resonator. The mobile wireless receiver includes a load associated with an outdoor lighting unit that draws energy from the load to power a light source associated with the outdoor lighting unit, and a third electromagnetic resonator configured to be coupled to the load and movable relative to at least one of the first electromagnetic resonator and the second electromagnetic resonator, wherein the third resonator is configured to be wirelessly coupled to at least one of the first electromagnetic resonator and the second electromagnetic resonator to provide resonant, non-radiative wireless power to the third electromagnetic resonator from at least one of the first electromagnetic resonator and the second electromagnetic resonator." The patent application was filed on Oct. 28, 2011 (13/283,822). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,154.PN.&OS=PN/8,441,154&RS=PN/8,441,154 Written by Kusum Sangma; edited by Anand Kumar. *** Lutron Electronics Assigned Patent ALEXANDRIA, Va., May 17 -- Lutron Electronics, Coopersburg, Pa., has been assigned a patent (8,441,197) developed by Mark S. Taipale, Harleysville, Pa., Aaron Dobbins, Hopedale, Mass., and Mehmet Ozbek, Allentown, Pa., for a "method of striking a lamp in an electronic dimming ballast circuit." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of striking a gas discharge lamp involves the steps of generating a high-frequency square-wave voltage having an operating frequency, generating a sinusoidal voltage from the high-frequency square-wave voltage, controlling the operating frequency to a low-end frequency, and increasing the amplitude of the sinusoidal voltage during successive pulse times and then decreasing the amplitude of the sinusoidal voltage towards the low-end amplitude at the end of each of the successive pulse times until the lamp has struck, where the length of each of the successive pulse times being greater than the length of the previous pulse time. A maximum amplitude of the sinusoidal voltage during each pulse time may be greater than a maximum amplitude of the sinusoidal voltage during the previous pulse time." The patent application was filed on April 4, 2011 (13/079,288). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,197.PN.&OS=PN/8,441,197&RS=PN/8,441,197 Written by Kusum Sangma; edited by Anand Kumar. *** Sand 9 Assigned Patent for Methods and Apparatus for Mechanical Resonating Structures ALEXANDRIA, Va., May 17 -- Sand 9, Cambridge, Mass., has been assigned a patent (8,441,176) developed by four co-inventors for "methods and apparatus for mechanical resonating structures." The co-inventors are Jan H. Kuypers, Cambridge, Mass., David M. Chen, Brookline, Mass., Guiti Zolfagharkhani, Brighton, Mass., and Alexei Gaidarzhy, Brighton, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Mechanical resonating structures and related methods are described. The mechanical resonating structures may provide improved efficiency over conventional resonating structures. Some of the structures have lengths and widths and are designed to vibrate in a direction approximately parallel to either the length or width. They may have boundaries bounding the length and width dimensions, which may substantially align with nodes or anti-nodes of vibration." The patent application was filed on Feb. 7, 2012 (13/367,759). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,176.PN.&OS=PN/8,441,176&RS=PN/8,441,176 Written by Kusum Sangma; edited by Anand Kumar. *** Brigham and Women's Hospital, Blood Center Research Foundation Assigned Patent ALEXANDRIA, Va., May 17 -- Brigham and Women's Hospital, Boston, and Blood Center Research Foundation, Milwaukee, have been assigned a patent (8,440,622) developed by four co-inventors for a "use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)." The co-inventors are Thomas P. Stossel, Belmont, Mass., Po-Shun Lee, Brookline, Mass., Bonnie Dittel, Whitefish Bay, Wis., and Katarzyna Maresz, Cracow, Poland. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to the use of gelsolin to treat neurologic diseases (e.g., multiple sclerosis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of neurologic diseases." The patent application was filed on March 14, 2007 (12/225,132). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,622.PN.&OS=PN/84,40,622&RS=PN/84,40,622 Written by Amal Ahmed; edited by Jaya Anand. *** Millennium Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Millennium Pharmaceuticals, Cambridge, Mass., has been assigned a patent (8,440,664) developed by six co-inventors for "heteroaryls and uses thereof." The co-inventors are David P. Cardin, Wilmington, Mass., Jeffrey Gaulin, Rockingham, N.H., Paul Greenspan, Acton, Mass., Christelle C. Renou, Stoneham, Mass., Stepan Vyskocil, Arlington, Mass., and Tianlin Xu, Shrewsbury, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention provides compounds of formula I: ##STR00001## wherein R.sup.1, R.sup.2, CY, Y.sub.1, Y.sub.2, X.sub.1, X.sub.2, and X.sub.3 are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders." The patent application was filed on April 18, 2012 (13/449,341). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,664.PN.&OS=PN/84,40,664&RS=PN/84,40,664 Written by Amal Ahmed; edited by Jaya Anand. *** Tufts Medical Center Assigned Patent ALEXANDRIA, Va., May 17 -- Tufts Medical Center, Boston, has been assigned a patent (8,440,627) developed by Athan Kuliopulos, Winchester, Mass., Lidija Covic, Lexington, Mass., and Nicole Kaneider, Innsbruck, Austria, for "G protein coupled receptor agonists and antagonists and methods of use." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates generally to G protein coupled receptors (GPCRs) and in particular to GPCR agonists and antagonists, use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with GPCRs, such as in treating conditions in which chemokine receptors play a role, e.g., sepsis, arthritis, inflammation and autoimmune diseases." The patent application was filed on Nov. 4, 2005 (11/667,042). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,627.PN.&OS=PN/84,40,627&RS=PN/84,40,627 Written by Amal Ahmed; edited by Jaya Anand. *** Theracos Assigned Patent ALEXANDRIA, Va., May 17 -- Theracos, Marlborough, Mass., has been assigned a patent (8,440,655) developed by Brian Seed, Boston, and Jordan Mechanic, Sunnyvale, Calif., for a "combination therapy for the treatment of diabetes." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides methods of treating, reducing, preventing, or inhibiting symptoms of diabetes and/or lowering plasma levels of HbA1c by co-administration of therapeutic or subtherapeutic doses of telenzepine and sertraline to a subject in need thereof." The patent application was filed on June 21, 2011 (13/165,549). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,655.PN.&OS=PN/84,40,655&RS=PN/84,40,655 Written by Amal Ahmed; edited by Jaya Anand. *** Erimos Pharmaceuticals, University of Maryland, Johns Hopkins University Assigned Patent ALEXANDRIA, Va., May 17 -- Erimos Pharmaceuticals, Houston, the University of Maryland, Baltimore, and Johns Hopkins University, Baltimore, have been assigned a patent (8,440,648) developed by seven co-inventors for "methods and compositions for treatment of intraepithelial neoplasia." The co-inventors are Neil Frazer, Cary, N.C., Jonathan Heller, Raleigh, N.C., Rocio Lopez, Durham, N.C., Melissa Rhodes, Raleigh, N.C., Ru Chih C. Huang, Baltimore, Richard Dalby, Timonium, Md., and Niharika Khanna, Ellicott City, Md. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides for compositions, kits and methods for treatment of intraepithelial neoplasia, where the compositions include catecholic butanes, which include NDGA derivatives." The patent application was filed on July 19, 2005 (11/572,349). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,648.PN.&OS=PN/84,40,648&RS=PN/84,40,648 Written by Amal Ahmed; edited by Jaya Anand. *** Duke University Assigned Patent ALEXANDRIA, Va., May 17 -- Duke University, Durham, N.C., has been assigned a patent (8,440,827) developed by Katherine J. Franz, Durham, N.C., and Katie L. Ciesienski, Chestnut Hill, Mass., for a "photolabile caged transition metal complexes and methods of using the same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides compounds of Formula I: (I) along with compositions comprising the same and methods of using the same, such as for photodynamic therapy in the treatment of cancer. ##STR00001##." The patent application was filed on July 23, 2009 (13/055,788). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,440,827&OS=8,440,827&RS=8,440,827 Written by Arpi Sharma; edited by Anand Kumar. *** Analog Devices Assigned Patent for Electrical Overstress Protection Using Through-silicon-via (TSV) ALEXANDRIA, Va., May 17 -- Analog Devices, Norwood, Mass., has been assigned a patent (8,441,104) developed by four co-inventors for an "electrical overstress protection using through-silicon-via (TSV)." The co-inventors are Lejun Hu, Somerville, Mass., Srivatsan Parthasarathy, Burlington, Mass., Michael Coln, Lexington, Mass., and Javier Salcedo, North Billerica, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A semiconductor device formed on a substrate includes a first diode junction formation, a second diode junction formation, and at least one through-silicon-via (TSV), in which a cathode and an anode of the first diode are cross-connected to an anode and cathode of the second diode through the at least one TSV for achieving electrical robustness in through-silicon-via based integrated circuits, including photosensitive devices and circuits for signal processing applications." The patent application was filed on Nov. 16, 2011 (13/297,571). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,104&OS=8,441,104&RS=8,441,104 Written by Arpi Sharma; edited by Anand Kumar. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1125249 (c) 2013 Targeted News Service |